Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 4 of 4 entries
View as:

A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA

Phase: N/A Priority: Normal
NCT ID: NCT01709760 Org: User:
Start: 11/30/12 End: 12/31/19 Due: 12/31/20

A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02685904 Org: User:
Start: 09/06/16 End: 12/31/18 Due: 12/31/19

A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01787149 Org: User:
Start: 09/30/13 End: 12/31/19 Due: 12/31/20

Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03522012 Org: User:
Start: 10/17/17 End: 12/20/18 Due: 12/20/19